CN Stock MarketDetailed Quotes

Hubei Guangji Pharmaceutical (000952)

Watchlist
  • 6.74
  • -0.26-3.71%
Market Closed Apr 17 15:00 CST
2.34BMarket Cap-9.99P/E (TTM)

Hubei Guangji Pharmaceutical (000952) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
Total operating revenue
-7.12%429.26M
-4.08%284.36M
-17.58%148.49M
-13.42%638.8M
-11.54%462.19M
-13.80%296.46M
56.27%180.16M
-7.50%737.82M
-2.57%522.49M
-8.54%343.91M
Operating revenue
-7.12%429.26M
-4.08%284.36M
-17.58%148.49M
-13.42%638.8M
-11.54%462.19M
-13.80%296.46M
56.27%180.16M
-7.50%737.82M
-2.57%522.49M
-8.54%343.91M
Other operating revenue
----
-61.25%2.89M
----
-51.40%3.75M
----
71.09%7.47M
----
176.27%7.71M
----
2,850.02%4.37M
Total operating cost
-12.10%552.38M
-9.10%367.76M
-20.46%190.32M
5.55%910.52M
6.24%628.44M
9.95%404.57M
49.09%239.27M
15.00%862.66M
11.88%591.55M
2.42%367.96M
Operating cost
-14.83%303.07M
-10.85%197.98M
-29.98%105.5M
-3.08%519.1M
-4.30%355.86M
-6.68%222.07M
59.92%150.66M
6.58%535.62M
6.19%371.86M
-5.46%237.97M
Operating tax surcharges
27.92%12.89M
28.94%8.62M
16.51%4.12M
13.86%15.58M
1.33%10.07M
-2.72%6.69M
-13.02%3.54M
1.39%13.69M
0.14%9.94M
1.16%6.87M
Operating expense
-20.45%22.58M
-19.55%15.61M
-6.83%9.72M
26.06%48.71M
-2.20%28.39M
-13.08%19.41M
6.88%10.44M
15.03%38.64M
24.84%29.03M
37.71%22.33M
Administration expense
-3.09%145.85M
-6.99%95.86M
1.02%50.73M
37.22%214.33M
44.13%150.5M
66.78%103.07M
62.31%50.22M
34.24%156.19M
21.67%104.42M
25.02%61.8M
Financial expense
-8.43%35.63M
-0.46%24.8M
12.25%9.34M
27.91%55.99M
42.22%38.91M
110.27%24.91M
64.06%8.32M
187.73%43.77M
244.53%27.36M
104.81%11.85M
-Interest expense (Financial expense)
-16.06%37M
-9.33%26.43M
6.53%9.95M
26.09%61.98M
38.06%44.08M
90.48%29.15M
68.45%9.34M
132.93%49.15M
124.88%31.93M
62.52%15.31M
-Interest Income (Financial expense)
53.75%-763.49K
50.55%-518.27K
46.10%-330.45K
40.45%-2.06M
32.67%-1.65M
30.76%-1.05M
-11.52%-613.08K
-72.70%-3.46M
-78.39%-2.45M
-60.43%-1.51M
Research and development
-27.61%32.36M
-12.46%24.88M
-32.22%10.91M
-23.99%56.82M
-8.65%44.7M
4.73%28.42M
-2.05%16.1M
8.37%74.75M
-5.11%48.94M
-7.45%27.14M
Credit Impairment Loss
349.08%1.76M
246.99%908.44K
113.25%164.96K
10,291.21%2.8M
111.76%392K
84.70%-618.03K
-352.74%-1.25M
99.38%-27.48K
27.34%-3.33M
-25.44%-4.04M
Asset Impairment Loss
31.40%-10.13M
76.47%-2.97M
148.37%358.51K
-142.64%-34.61M
-737.73%-14.76M
-570.96%-12.61M
-190.29%-741.26K
-85.55%-14.26M
254.61%2.32M
310.08%2.68M
Other net revenue
524.23%18.11M
123.88%1.9M
-36.65%1.85M
-184.74%-46.17M
2.24%-4.27M
-101.12%-7.94M
2,863.21%2.92M
-221.95%-16.22M
-140.99%-4.37M
-138.51%-3.95M
Invest income
615.95%18.8M
----
----
-178.55%-27.92M
47.87%-3.64M
42.59%-2.92M
71.36%-855.48K
-259.03%-10.02M
-241.43%-6.99M
-209.47%-5.09M
-Including: Investment income associates
95.18%-102.14K
----
----
-212.65%-27.92M
69.70%-2.12M
70.83%-1.49M
71.36%-855.48K
-305.89%-8.93M
-266.08%-6.99M
-215.80%-5.09M
Asset deal income
----
----
----
-1,048.26%-2.4M
----
----
--84.38K
105.88%253.34K
----
----
Other revenue
-44.19%7.67M
-51.82%3.95M
-76.62%1.33M
103.41%15.96M
277.32%13.75M
227.22%8.21M
262.32%5.68M
-66.52%7.85M
-62.23%3.64M
-69.30%2.51M
Operating profit
38.42%-105.01M
29.77%-81.5M
28.84%-39.98M
-125.37%-317.9M
-132.26%-170.52M
-314.56%-116.06M
-24.04%-56.19M
-332.07%-141.05M
-502.90%-73.42M
-203.61%-28M
Add:Non operating Income
-94.05%65.82K
-99.22%8.31K
-99.96%401.1
37.38%1.65M
20.68%1.11M
8,019.56%1.06M
350,685.78%1.07M
33.21%1.2M
1.99%916.89K
-97.15%13.06K
Less:Non operating expense
28.42%2.04M
891.04%254.46K
122.54%204K
398.36%4.04M
121.48%1.59M
-96.02%25.68K
-82.38%91.67K
-49.22%811.45K
-50.85%717.04K
-48.23%645.47K
Total profit
37.43%-106.99M
28.93%-81.75M
27.20%-40.19M
-127.70%-320.29M
-133.55%-171M
-301.79%-115.02M
-20.49%-55.2M
-334.12%-140.67M
-514.53%-73.22M
-209.14%-28.63M
Less:Income tax cost
-97.08%42.63K
2.56%554.34K
98.73%-6.81K
-143.92%-5.16M
202.36%1.46M
207.72%540.49K
-27.45%-535.01K
-5.25%11.75M
-133.40%-1.42M
-116.76%-501.75K
Net profit
37.94%-107.03M
28.78%-82.3M
26.50%-40.18M
-106.76%-315.13M
-140.21%-172.46M
-310.88%-115.56M
-20.42%-54.67M
-419.63%-152.41M
-492.90%-71.79M
-221.04%-28.13M
Net profit from continuing operation
37.94%-107.03M
28.78%-82.3M
26.50%-40.18M
-106.76%-315.13M
-140.21%-172.46M
-310.88%-115.56M
-20.42%-54.67M
-419.63%-152.41M
-492.90%-71.79M
-221.04%-28.13M
Less:Minority Profit
29.91%-9.73M
23.88%-6.79M
5.95%-3.91M
-63.10%-19.84M
-188.11%-13.88M
-284.21%-8.92M
-206.02%-4.16M
-359.16%-12.17M
-194.82%-4.82M
-59.13%-2.32M
Net profit of parent company owners
38.64%-97.3M
29.19%-75.52M
28.20%-36.27M
-110.55%-295.29M
-136.76%-158.58M
-313.28%-106.65M
-14.69%-50.51M
-378.64%-140.25M
-436.44%-66.98M
-204.49%-25.8M
Earning per share
Basic earning per share
37.99%-0.2789
28.40%-0.2158
27.33%-0.1037
-111.81%-0.8392
-137.74%-0.4498
-313.44%-0.3014
-14.71%-0.1427
-376.48%-0.3962
-435.46%-0.1892
-203.70%-0.0729
Diluted earning per share
38.75%-0.2755
29.26%-0.2132
27.33%-0.1037
-108.24%-0.8209
-137.74%-0.4498
-313.44%-0.3014
-14.71%-0.1427
-376.24%-0.3942
-427.90%-0.1892
-201.82%-0.0729
Other composite income
115.56%247.58
105.96%268.18
101.82%82.74
-151.79%-7.24K
-125.70%-1.59K
-125.92%-4.5K
-265.79%-4.54K
116.26%13.97K
154.63%6.19K
263.92%17.36K
Other composite income of parent company owners
115.56%247.58
105.96%268.18
101.82%82.74
-151.79%-7.24K
-125.70%-1.59K
-125.92%-4.5K
-265.79%-4.54K
116.26%13.97K
154.63%6.19K
263.92%17.36K
Total composite income
37.94%-107.03M
28.78%-82.3M
26.51%-40.18M
-106.79%-315.14M
-140.23%-172.46M
-311.15%-115.57M
-20.44%-54.67M
-419.56%-152.4M
-493.11%-71.79M
-221.02%-28.11M
Total composite income of parent company owners
38.64%-97.3M
29.19%-75.51M
28.20%-36.27M
-110.58%-295.3M
-136.79%-158.58M
-313.58%-106.65M
-14.71%-50.51M
-378.57%-140.23M
-436.60%-66.97M
-204.46%-25.79M
Total composite income of minority owners
29.91%-9.73M
23.88%-6.79M
5.95%-3.91M
-63.10%-19.84M
-188.11%-13.88M
-284.21%-8.92M
-206.02%-4.16M
-359.16%-12.17M
-194.82%-4.82M
-59.13%-2.32M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
LianDa Certified Public Accountants (Special General Partnership)
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023
Total operating revenue -7.12%429.26M-4.08%284.36M-17.58%148.49M-13.42%638.8M-11.54%462.19M-13.80%296.46M56.27%180.16M-7.50%737.82M-2.57%522.49M-8.54%343.91M
Operating revenue -7.12%429.26M-4.08%284.36M-17.58%148.49M-13.42%638.8M-11.54%462.19M-13.80%296.46M56.27%180.16M-7.50%737.82M-2.57%522.49M-8.54%343.91M
Other operating revenue -----61.25%2.89M-----51.40%3.75M----71.09%7.47M----176.27%7.71M----2,850.02%4.37M
Total operating cost -12.10%552.38M-9.10%367.76M-20.46%190.32M5.55%910.52M6.24%628.44M9.95%404.57M49.09%239.27M15.00%862.66M11.88%591.55M2.42%367.96M
Operating cost -14.83%303.07M-10.85%197.98M-29.98%105.5M-3.08%519.1M-4.30%355.86M-6.68%222.07M59.92%150.66M6.58%535.62M6.19%371.86M-5.46%237.97M
Operating tax surcharges 27.92%12.89M28.94%8.62M16.51%4.12M13.86%15.58M1.33%10.07M-2.72%6.69M-13.02%3.54M1.39%13.69M0.14%9.94M1.16%6.87M
Operating expense -20.45%22.58M-19.55%15.61M-6.83%9.72M26.06%48.71M-2.20%28.39M-13.08%19.41M6.88%10.44M15.03%38.64M24.84%29.03M37.71%22.33M
Administration expense -3.09%145.85M-6.99%95.86M1.02%50.73M37.22%214.33M44.13%150.5M66.78%103.07M62.31%50.22M34.24%156.19M21.67%104.42M25.02%61.8M
Financial expense -8.43%35.63M-0.46%24.8M12.25%9.34M27.91%55.99M42.22%38.91M110.27%24.91M64.06%8.32M187.73%43.77M244.53%27.36M104.81%11.85M
-Interest expense (Financial expense) -16.06%37M-9.33%26.43M6.53%9.95M26.09%61.98M38.06%44.08M90.48%29.15M68.45%9.34M132.93%49.15M124.88%31.93M62.52%15.31M
-Interest Income (Financial expense) 53.75%-763.49K50.55%-518.27K46.10%-330.45K40.45%-2.06M32.67%-1.65M30.76%-1.05M-11.52%-613.08K-72.70%-3.46M-78.39%-2.45M-60.43%-1.51M
Research and development -27.61%32.36M-12.46%24.88M-32.22%10.91M-23.99%56.82M-8.65%44.7M4.73%28.42M-2.05%16.1M8.37%74.75M-5.11%48.94M-7.45%27.14M
Credit Impairment Loss 349.08%1.76M246.99%908.44K113.25%164.96K10,291.21%2.8M111.76%392K84.70%-618.03K-352.74%-1.25M99.38%-27.48K27.34%-3.33M-25.44%-4.04M
Asset Impairment Loss 31.40%-10.13M76.47%-2.97M148.37%358.51K-142.64%-34.61M-737.73%-14.76M-570.96%-12.61M-190.29%-741.26K-85.55%-14.26M254.61%2.32M310.08%2.68M
Other net revenue 524.23%18.11M123.88%1.9M-36.65%1.85M-184.74%-46.17M2.24%-4.27M-101.12%-7.94M2,863.21%2.92M-221.95%-16.22M-140.99%-4.37M-138.51%-3.95M
Invest income 615.95%18.8M---------178.55%-27.92M47.87%-3.64M42.59%-2.92M71.36%-855.48K-259.03%-10.02M-241.43%-6.99M-209.47%-5.09M
-Including: Investment income associates 95.18%-102.14K---------212.65%-27.92M69.70%-2.12M70.83%-1.49M71.36%-855.48K-305.89%-8.93M-266.08%-6.99M-215.80%-5.09M
Asset deal income -------------1,048.26%-2.4M----------84.38K105.88%253.34K--------
Other revenue -44.19%7.67M-51.82%3.95M-76.62%1.33M103.41%15.96M277.32%13.75M227.22%8.21M262.32%5.68M-66.52%7.85M-62.23%3.64M-69.30%2.51M
Operating profit 38.42%-105.01M29.77%-81.5M28.84%-39.98M-125.37%-317.9M-132.26%-170.52M-314.56%-116.06M-24.04%-56.19M-332.07%-141.05M-502.90%-73.42M-203.61%-28M
Add:Non operating Income -94.05%65.82K-99.22%8.31K-99.96%401.137.38%1.65M20.68%1.11M8,019.56%1.06M350,685.78%1.07M33.21%1.2M1.99%916.89K-97.15%13.06K
Less:Non operating expense 28.42%2.04M891.04%254.46K122.54%204K398.36%4.04M121.48%1.59M-96.02%25.68K-82.38%91.67K-49.22%811.45K-50.85%717.04K-48.23%645.47K
Total profit 37.43%-106.99M28.93%-81.75M27.20%-40.19M-127.70%-320.29M-133.55%-171M-301.79%-115.02M-20.49%-55.2M-334.12%-140.67M-514.53%-73.22M-209.14%-28.63M
Less:Income tax cost -97.08%42.63K2.56%554.34K98.73%-6.81K-143.92%-5.16M202.36%1.46M207.72%540.49K-27.45%-535.01K-5.25%11.75M-133.40%-1.42M-116.76%-501.75K
Net profit 37.94%-107.03M28.78%-82.3M26.50%-40.18M-106.76%-315.13M-140.21%-172.46M-310.88%-115.56M-20.42%-54.67M-419.63%-152.41M-492.90%-71.79M-221.04%-28.13M
Net profit from continuing operation 37.94%-107.03M28.78%-82.3M26.50%-40.18M-106.76%-315.13M-140.21%-172.46M-310.88%-115.56M-20.42%-54.67M-419.63%-152.41M-492.90%-71.79M-221.04%-28.13M
Less:Minority Profit 29.91%-9.73M23.88%-6.79M5.95%-3.91M-63.10%-19.84M-188.11%-13.88M-284.21%-8.92M-206.02%-4.16M-359.16%-12.17M-194.82%-4.82M-59.13%-2.32M
Net profit of parent company owners 38.64%-97.3M29.19%-75.52M28.20%-36.27M-110.55%-295.29M-136.76%-158.58M-313.28%-106.65M-14.69%-50.51M-378.64%-140.25M-436.44%-66.98M-204.49%-25.8M
Earning per share
Basic earning per share 37.99%-0.278928.40%-0.215827.33%-0.1037-111.81%-0.8392-137.74%-0.4498-313.44%-0.3014-14.71%-0.1427-376.48%-0.3962-435.46%-0.1892-203.70%-0.0729
Diluted earning per share 38.75%-0.275529.26%-0.213227.33%-0.1037-108.24%-0.8209-137.74%-0.4498-313.44%-0.3014-14.71%-0.1427-376.24%-0.3942-427.90%-0.1892-201.82%-0.0729
Other composite income 115.56%247.58105.96%268.18101.82%82.74-151.79%-7.24K-125.70%-1.59K-125.92%-4.5K-265.79%-4.54K116.26%13.97K154.63%6.19K263.92%17.36K
Other composite income of parent company owners 115.56%247.58105.96%268.18101.82%82.74-151.79%-7.24K-125.70%-1.59K-125.92%-4.5K-265.79%-4.54K116.26%13.97K154.63%6.19K263.92%17.36K
Total composite income 37.94%-107.03M28.78%-82.3M26.51%-40.18M-106.79%-315.14M-140.23%-172.46M-311.15%-115.57M-20.44%-54.67M-419.56%-152.4M-493.11%-71.79M-221.02%-28.11M
Total composite income of parent company owners 38.64%-97.3M29.19%-75.51M28.20%-36.27M-110.58%-295.3M-136.79%-158.58M-313.58%-106.65M-14.71%-50.51M-378.57%-140.23M-436.60%-66.97M-204.46%-25.79M
Total composite income of minority owners 29.91%-9.73M23.88%-6.79M5.95%-3.91M-63.10%-19.84M-188.11%-13.88M-284.21%-8.92M-206.02%-4.16M-359.16%-12.17M-194.82%-4.82M-59.13%-2.32M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------LianDa Certified Public Accountants (Special General Partnership)------Daxin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More